DIABETES MELLITUS TYPE 1
Clinical trials for DIABETES MELLITUS TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new DIABETES MELLITUS TYPE 1 trials appear
Sign up with your email to follow new studies for DIABETES MELLITUS TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising diabetes delay study halted due to lack of participants
Disease control TerminatedThis study tested a low dose of a drug called ATG to see if it could delay or prevent type 1 diabetes in people at high risk. Only 2 people enrolled, so the study was stopped early. The goal was to measure how long it took for participants to develop full diabetes.
Matched conditions: DIABETES MELLITUS TYPE 1
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
Can a nasal spray stop low blood sugar danger?
Knowledge-focused TerminatedThis study aimed to find a way to prevent hypoglycemia unawareness—a dangerous condition where people with diabetes can't feel low blood sugar. Researchers tested two drugs, naloxone (as a nasal spray) and diazoxide (a pill), in healthy volunteers to see if they could improve the…
Matched conditions: DIABETES MELLITUS TYPE 1
Phase: PHASE4 • Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC